Cook Pharmica Names Victor Vinci Vice President and Chief Scientific Officer

BLOOMINGTON, Ind.--(BUSINESS WIRE)--Victor Vinci, Ph.D., has joined Cook Pharmica’s leadership team as vice president and chief scientific officer. Vinci will be responsible for guiding the scientific direction of Cook Pharmica, applying his more than 20 years of broad technical, managerial and leadership experience.

“Victor is a great complement to the Pharmica leadership team. His vast experience in biopharmaceutical process development and operations will further ensure our ability to continually meet the needs of our clients and provide additional technical expertise for our clients to draw upon”

“Victor is a great complement to the Pharmica leadership team. His vast experience in biopharmaceutical process development and operations will further ensure our ability to continually meet the needs of our clients and provide additional technical expertise for our clients to draw upon,” said Cook Pharmica president Tedd Green. “We’re carefully investing in people, equipment and facilities to make sure our customers are getting the service they’ve come to expect from Pharmica.”

Prior to joining Cook, Vinci worked for many years at Eli Lilly and Company in Indianapolis and was responsible for leading bioprocess operations and development efforts. He also spent six years at Merck as a manufacturing science and technology lead and section head. He holds a Master of Science and a Doctorate in microbiology from The Ohio State University, and Bachelors of Science in both chemistry and microbiology from Bowling Green State University.

“I’m excited to be a part of what’s happening at Cook Pharmica,” said Vinci. “The company offers a wonderful service as a one-stop shop for contract manufacturing, including an expansive offering of process development expertise. I’m looking forward to applying my experience to the organization as it continues to grow.”

About Cook Pharmica

Cook Pharmica is an integrated contract development and manufacturing organization providing the pharmaceutical and biopharmaceutical industries with drug substance manufacturing from mammalian cell culture; analytical and formulation development; parenteral manufacturing in vials and prefilled syringes; lyophilization; and secondary packaging. Operating with more than 400 employees in a 900,000 square foot, $200 million facility in Bloomington, Ind., Cook Pharmica’s mission is to consolidate and simplify clients’ contract manufacturing into one source at one location. Founded in 2004, Cook Pharmica, the biopharmaceutical manufacturing division of Cook Medical, is a privately held, wholly owned subsidiary of parent company Cook Group. For more information, visit www.cookpharmica.com.

Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50408868&lang=en